The strong frontal lobe preference of IDH1/2-mutant gliomas may be associated with their epigenetic features in OLIG2-positive precursor cells existing in this region, potentially driving selective expansion of IDH1/2-mutant clones through aberrant metabolic reprogramming [30–32]. Here, IDH1 is linked to central nervous system cancer.